Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D

The Company will accelerate the commercial deployment of…


Therapixel-presents-MammoScreen-ECR 2021

Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021

Stop by our booth to learn more about our FDA-cleared and…


Therapixel participates at the JFR 2020

Therapixel participates in the Journées Francophones de Radiologie 2020

Experience the Award-winning MammoScreen™ at our virtual…


Therapixel is certified ISO 27001

Therapixel is now ISO/IEC 27001 certified

Our information security management system is compliant…


MammoScreen received 510(k) clearance

Therapixel receives FDA 510(k) clearance for MammoScreen™

AI-powered reading aid for screening mammography improves…


Therapixel presents at ECR-Therapixel

Therapixel presents the results of its Reader study at the Virtual ECR 2020

Do not miss our research presentation (RPS 702-7) at the…